2-（3-氯-4-氟苯基）-2,2-二氟乙酸 | 1027514-19-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-（3-氯-4-氟苯基）-2,2-二氟乙酸
• 英文名称: 2-(3-chloro-4-fluorophenyl)-2,2-difluoroacetic acid
• CAS: 1027514-19-7
• 化学式: C₈H₄ClF₃O₂
• 分子量: 224.567
• InChiKey: DFBBKEDRIACDMM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  3-(5-(aminomethyl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione 、 甲烷磺酸 、 2-（3-氯-4-氟苯基）-2,2-二氟乙酸 、 N,N-二异丙基乙胺 、 2-(7-偶氮苯并三氮唑)-N,N,N',N'-四甲基脲六氟磷酸酯 在 乙腈 、 水 、 desired product 作用下， 以 二甲基亚砜 、 N,N-二甲基甲酰胺 为溶剂， 反应 18.33h， 以to give 2-(3-chloro-4-fluorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide as a white solid的产率得到2-(3-chloro-4-fluorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
  参考文献：
  名称：

  ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF

  摘要：

  本发明公开了用于治疗、预防或管理癌症的I式化合物。还公开了治疗、预防或管理癌症的方法，例如治疗白血病，包括给予这些化合物。在某些实施例中，治疗方法包括给予本文提供的一种化合物与第二剂量的药物联合使用。还公开了包含这些化合物的制药组合物和单剂量形式。

  公开号：

  US20160009683A1

文献信息

• ORGANIC ELECTRONIC COMPONENT HAVING A CHARGE CARRIER GENERATION LAYER AND THE USE OF A ZINC COMPLEX AS A P-TYPE DOPANT IN CHARGE CARRIER GENERATION LAYERS
  申请人：OSRAM OLED GmbH

  公开号：US20180277778A1

  公开（公告）日：2018-09-27

  The invention relates to an organic electronic component ( 100 ) comprising at least one charge generation layer ( 5 ) which has an organically p-doped region ( 5 a ) that contains a zinc complex as a p-dopant, said zinc complex in turn containing at least one ligand L of the following structure: formula (I) wherein R1 and R2 can be oxygen, sulphur, selenium, NH or NR4 independently from one another, wherein R4 is selected from the group containing alkyl or aryl and which can be bonded to R3; and wherein R3 is selected from the group containing alkyl, long-chain alkyl, cycloalkyl, halogen alkyl, at least partially halogenated long-chain alkyl, halogen cycloalkyl, aryl, arylene, halogen aryl, heteroaryl, heteroarylene, heterocyclic alkylene, heterocycloalkyl, halogen heteroaryl, alkenyl, halogen alkenyl, alkynyl, halogen alkynyl, ketoaryl, halogen ketoaryl, ketoheteroaryl, ketoalkyl, halogen ketoalkyl, ketoalkenyl, halogen ketoalkenyl, halogen alkyl aryl, and halogen alkyl heteroaryl, wherein, for suitable groups, one or a number of non-adjacent CH2 groups can be replaced by —O—, —S—, —NH—, —NR ∘∘∘ —, —SiR ∘ R ∘∘ —, —CO—, —COO—, —COR ∘ OR ∘∘ —, —OCO—, —OCO—O—, —SO2-, —S—CO—, —CO—S—, —O—CS—, —CS—O—, —CY1=CY2 or —C≡C— independently from one another, and in such a way that O and/or S atoms are not directly bonded to one another, and are replaced optionally with aryl- or heteroaryl preferably containing between 1 and 30 C atoms (terminal CH3 groups are understood to be CH2 groups in the sense of CH2-H). The invention further relates to the use of a zinc complex as a p-dopant in charge generation layers.

  本发明涉及一种有机电子元件（100），包括至少一个具有有机p-掺杂区域（5a）的电荷生成层（5），该区域含有锌络合物作为p-掺杂剂，所述锌络合物又包含至少一个具有以下结构的配体L：式（I），其中R1和R2可以分别独立地为氧、硫、硒、NH或NR4，其中R4选自含有烷基或芳基的基团，可以与R3结合；R3选自含有烷基、长链烷基、环烷基、卤代烷基、至少部分卤代长链烷基、卤代环烷基、芳基、芳烯基、卤代芳基、杂环芳基、杂环芳烯基、杂环烷基、卤代杂环芳基、烯基、卤代烯基、炔基、卤代炔基、酮基芳基、卤代酮基芳基、酮基杂环芳基、酮基烷基、卤代酮基烷基、酮基烯基、卤代酮基烯基、卤代烷基芳基和卤代烷基杂环芳基的基团，对于适当的基团，一个或多个非相邻的CH2基团可以被—O—、—S—、—NH—、—NR∘∘∘—、—SiR∘R∘∘—、—CO—、—COO—、—COR∘OR∘∘—、—OCO—、—OCO—O—、—SO2-、—S—CO—、—CO—S—、—O—CS—、—CS—O—、—CY1=CY2或—C≡C—中的一个或多个代替，且使O和/或S原子不直接结合，可选地用含有1至30个C原子的芳基或杂环芳基替换（末端CH3基团在CH2-H的意义上被理解为CH2基团）。该发明还涉及在电荷生成层中使用锌络合物作为p-掺杂剂。
• [EN] ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF<br/>[FR] COMPOSÉS ANTIPROLIFÉRATIFS ET MÉTHODES D'UTILISATION DESDITS COMPOSÉS
  申请人：CELGENE CORP

  公开号：WO2016007848A1

  公开（公告）日：2016-01-14

  Compounds of formula (I) for treating, preventing or managing cancer are disclosed. Also disclosed are methods of treating, preventing or managing cancer, such as leukemia, comprising administering the compounds. In certain embodiments, the method of treatment comprise administering a compound provided herein in combination with a second agent. Pharmaceutical compositions and single unit dosage forms comprising the compounds are also disclosed. In Formula (I) R1 is optionally substituted cycloalkyi, aryl, heteroaryl or heterocyclyl; and R2 and R3 are each halo.

  本发明揭示了化学式(I)的化合物，用于治疗、预防或管理癌症。同时，还揭示了治疗、预防或管理癌症的方法，例如白血病，包括给予该化合物。 在某些实施例中，治疗方法包括联合给予本文提供的化合物和第二药物。还揭示了包含该化合物的制药组合物和单剂量形式。 在化学式(I)中，R1是可选的取代环烷基，芳基，杂芳基或杂环烷基；R2和R3均为卤素。
• Main group metal complexes as p-dopants for organic electronic matrix materials
  申请人：Siemens Aktiengesellschaft

  公开号：US10305047B2

  公开（公告）日：2019-05-28

  A metal complex of a metal from groups 13 to 16 uses a ligand of the structure (I), where R.sup.1 and R.sup.2 can independently be oxygen, sulfur, selenium, NH or NR.sup.4, where R.sup.4 an alkyl or aryl and can be connected to R.sup.3. R.sup.3 is an alkyl, long-chain alkyl, alkoxy, long-chain alkoxy, cycloalkyl, halogenalkyl, aryl, arylene, halogenaryl, heteroaryl, heteroarylene, heterocycloalkylene, heterocycloalkyl, halogenheteroaryl, alkenyl, halogenalkenyl, alkynyl, halogenalkynyl, ketoaryl, halogenketoaryl, ketoheteroaryl, ketoalkyl, halogenketoalkyl, ketoalkenyl, halogenketoalkenyl, where in suitable radicals, one or more non-adjacent CH.sup.2-groups can be substituted independently of one another by —O—, —S—, —NH—, —NR.sup.o-, —SiR.sup.oR.sup.oo-, —CO—, —COO—, —OCO—, —OCO—O—, —SO.sub.2-, —S—CO—, —CO—S—, —CY1═CY2 or —C.dbd.C—, specifically in such a way that O and/or S atoms are not connected directly to one another, are likewise optionally substituted with aryl- or heteroaryl preferably containing 1 to 30 C atoms, as a dopant for matrix materials in organic electronic components.

  第 13 至第 16 组金属的金属络合物使用结构为(I)的配体，其中 R.sup.1 和 R.sup.2 可以独立地为氧、硫、硒、NH 或 NR.sup.4，R.sup.4 为烷基或芳基并可与 R.sup.3 连接。是烷基、长链烷基、烷氧基、长链烷氧基、环烷基、卤代烷基、芳基、芳烯基、卤代芳基、杂芳基、杂芳烯、杂环烷基、杂环烷基、卤代杂芳基、烯基、卤代烯基、炔基、炔烃基、炔烃基、炔烃基、炔烃基、炔烃基、炔烃基、炔烃基、炔烃基卤代烯基、炔基、卤代炔基、酮芳基、卤代酮芳基、酮异芳基、酮烷基、卤代酮烷基、酮烯基、卤代酮烯基。sup.2--S-CO-、-CO-S-、-CY1═CY2 或-C.dbd.C-，特别是以 O 原子和/或 S 原子不直接相连的方式，同样任选地被芳基或杂芳基取代，最好含有 1 至 30 个 C 原子，作为有机电子元件中基质材料的掺杂剂。
• Main group metal complexes as P-dopants for organic electronic matrix materials
  申请人：SIEMENS AKTIENGESELLSCHAFT

  公开号：US10411197B2

  公开（公告）日：2019-09-10

  A metal complex of a metal from groups 13 to 16 uses a ligand of the structure (I), where R1 and R2 can independently be oxygen, sulfur, selenium, NH or NR4, where R4 an alkyl or aryl and can be connected to R3. R3 is an alkyl, long-chain alkyl, alkoxy, long-chain alkoxy, cycloalkyl, halogenalkyl, aryl, arylene, halogenaryl, heteroaryl, heteroarylene, heterocycloalkylene, heterocycloalkyl, halogenheteroaryl, alkenyl, halogenalkenyl, alkynyl, halogenalkynyl, ketoaryl, halogenketoaryl, ketoheteroaryl, ketoalkyl, halogenketoalkyl, ketoalkenyl, halogenketoalkenyl, where in suitable radicals, one or more non-adjacent CH2— groups can be substituted independently of one another by —O—, —S—, —NH—, —NRo—, —SiRoRoo—, —CO—, —COO—, —OCO—, —OCO—O—, —SO2—, —S—CO—, —CO—S—, —CY1=CY2 or —C═C—, specifically in such a way that O and/or S atoms are not connected directly to one another, are likewise optionally substituted with aryl- or heteroaryl preferably containing 1 to 30 C atoms, as a dopant for matrix materials in organic electronic components.

  第 13 至 16 组金属的金属络合物使用结构 (I) 的配体，其中 R1 和 R2 可以独立地为氧、硫、硒、NH 或 NR4，其中 R4 为烷基或芳基并可与 R3 连接。R3 是烷基、长链烷基、烷氧基、长链烷氧基、环烷基、卤代烷基、芳基、芳烯基、卤代芳基、杂芳基、杂芳烯基、杂环烷基、杂环烷基、卤代杂芳基、烯基、卤代烯基、炔基、卤代炔基、卤代炔基、卤代炔基、卤代炔基、卤代炔基、卤代炔基、卤代炔基、酮芳基、卤代酮芳基、酮异芳基、酮烷基、卤代酮烷基、酮烯基、卤代酮烯基，其中在合适的基团中，一个或多个不相邻的 CH2- 基团可独立地被-O-取代、-S-、-NH-、-NRo-、-SiRoRoo-、-CO-、-COO-、-OCO-、-OCO-O-、-SO2-、-S-CO-、-CO-S-、-CY1=CY2 或 -C═C-，特别是 O 原子和/或 S 原子不直接相互连接，同样可任选被芳基或杂芳基取代，最好含有 1 至 30 个 C 原子，作为有机电子元件中基质材料的掺杂剂。
• Materials for electronic devices
  申请人：Merck Patent Gmbh

  公开号：US10396297B2

  公开（公告）日：2019-08-27

  The present application relates to a material comprising a monoarylamine of a defined formula and a p-dopant of a defined formula. The present application further relates to the use of said material in an organic layer of an electronic device, the device preferably being an organic electroluminescent device (OLED).

  本申请涉及一种由定义式的单芳基胺和定义式的对掺杂剂组成的材料。本申请还涉及在电子设备的有机层中使用所述材料，该设备最好是有机电致发光设备（OLED）。